Hythiam, Inc. (NASDAQ: HYTM) is focused on providing comprehensive behavioral health management services to health plans, employers, criminal justice, and government agencies. Additionally, the company researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment programs. Currently, Hythiam provides initial disease management offerings that incorporate medical and behavioral treatments for substance dependence. For further information, visit the Company’s web site at www.hythiam.com.
- 17 years ago
QualityStocks
Hythiam, Inc. (NASDAQ: HYTM)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Issues Investor Update Highlighting Accelerated Revenue Growth, Global Partnerships, and Platform Expansion
Datavault AI (NASDAQ: DVLT), a leader in data monetization, credentialing, and digital engagement technologies, today…
-
QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Bioscience Publish Landmark Review Defining Sub-15 nm Nanoparticles as New Frontier in Drug Delivery
Oncotelic Therapeutics (OTCQB: OTLC), and joint venture partner Sapu Bioscience today announced the publication of…
-
QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) to Host Webcast and Investor Q&A Following Q3 2025 Financial Results
Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company focused on performance-driven innovation, today announced…